GSK-partnered Hansoh Pharma reports positive Phase III lung cancer data.
GSK plc shared an announcement from its licensor, HansohPharmaceutical Group Co., Ltd., confirming that the pivotal phase III ARTEMIS-008 trial evaluating risvutatug rezetecan(Ris-Rez) met its primary endpoint...
Army Hospital R&R Performs First Robotic Stereotactic Brain Stem Biopsy
In a landmark achievement for military medicine, the Neurosurgery Department at the Army Hospital Research & Referral (R&R) has successfully performed the first-ever robotic...
Johnson & Johnson Secures FDA Approval for Dual-Energy Cardiac Ablation Catheter
Johnson & Johnson has secured U.S. regulatory clearance for its newest electrophysiology device, the Dual Energy THERMOCOOL SMARTTOUCH SF Platform. The system lets doctors...
Vertex to Acquire Crinetics Pharmaceuticals for $10.0 Billion, Expanding Rare Endocrine Disease Portfolio
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. announced a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in...
World’s First Once-Weekly Basal Insulin Now in India as Novo Nordisk Launches Awiqli®
In a major milestone for diabetes management, India has become one of the first countries globally to introduce Awiqli, the world’s first once-a-week basal insulin...
Pinnacle Life Science Becomes First to Launch Generic Blood Cancer Drug Venetoclax in India, Reducing Costs by 75%
In a major breakthrough for affordable oncology care, Pinnacle Life Science Pvt. Ltd., a subsidiary of Aarti Drugs, has officially launched Venetoclax in India. With this milestone, Pinnacle becomes the...
